Delivery Order SPE2DB22D2006-SPE2DB25FW4HB
- Not listed
- The Defense Logistics Agency awarded a $47,741.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). The delivery order, which is unclassified as a set-aside contract, is scheduled for completion by September 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract issued under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,737.75 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $7,668.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Kerendia 20 mg tablets (30-count) with a ceiling value of $3,084.90 under a firm fixed-price contract. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 26, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Kerendia 20 mg tablets (30-count units) with a ceiling value of $27,471.06. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on June 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order valued at $19,097.35 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) on September 17, 2025, with completion expected by September 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,344.93 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count package) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,642.05 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count packages) under a firm fixed price contract. The award was made on September 16, 2025, with an ultimate completion date of September 17, 2025, and represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 17, 2025, for the supply of Kerendia 20 mg tablets (30-count units) valued at $2,799.21. This firm fixed-price delivery order, with an ultimate completion date of May 19, 2025, represents a non-competitive, non-set-aside award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count supply) under a firm fixed-price contract valued at $1,492.08, with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside delivery order was executed on September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4HBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging) valued at $6,857.16. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems worldwide. As a prime contractor with extensive experience fulfilling federal medical supply requirements, AmerisourceBergen supplies a broad portfolio of pharmaceutical products across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent success in competitive federal procurement, demonstrated through numerous contract awards ranging from minimal to substantial values, reflects its capability to meet rigorous federal medical supply standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 9/23/25 |